glenmark pharma India's Glenmark to conduct trials for potential Covid19 drug Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9% « Previous1Next » 1 of 1